PDB19 THE COST-EFFECTIVENESS OF PIOGLITAZONE COMPARED WITH SITAGLIPTIN- AN ECONOMIC EVALUATION USING A VALIDATED ECONOMIC MODEL FROM ATHIRD PARTY PAYER PERSPECTIVE IN THE USA
Abstract
Authors
M Minshall M St. Charles B Pandya RW Baran M Bron